Current role
Carole Huntsman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Madrigal Pharmaceuticals, Inc. (MDGL)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Madrigal Pharmaceuticals, Inc. (MDGL) | Executive Vice President and Chief Commercial Officer | $540,313 | $5,441,736 |
| 2024 | Madrigal Pharmaceuticals, Inc. (MDGL) | Executive Vice President and Chief Commercial Officer | $525,000 | $3,949,441 |
| 2023 | Madrigal Pharmaceuticals, Inc. (MDGL) | Chief Commercial Officer | $61,922 | $3,142,354 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.